Vaccines, Attenuated

"Vaccines, Attenuated" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity.

Descriptor ID	D014613
MeSH Number(s)	D20.215.894.811
Concept/Terms	Vaccines, Attenuated Vaccines, Attenuated Attenuated Vaccines Vaccines, Live, Attenuated

Below are MeSH descriptors whose meaning is more general than "Vaccines, Attenuated".

Chemicals and Drugs [D]
Complex Mixtures [D20]
Biological Products [D20.215]
Vaccines [D20.215.894]
Vaccines, Attenuated [D20.215.894.811]

Below are MeSH descriptors whose meaning is related to "Vaccines, Attenuated".

Below are MeSH descriptors whose meaning is more specific than "Vaccines, Attenuated".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Vaccines, Attenuated" by people in this website by year, and whether "Vaccines, Attenuated" was a major or minor topic of these publications.

Bar chart showing 48 publications over 21 distinct years, with a maximum of 5 publications in 2009 and 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	1	0	1
2000	0	1	1
2003	0	2	2
2004	1	1	2
2005	0	1	1
2006	1	1	2
2009	0	5	5
2010	0	1	1
2011	1	2	3
2012	1	4	5
2013	1	1	2
2014	0	2	2
2015	0	4	4
2016	1	3	4
2017	1	2	3
2018	0	1	1
2019	0	2	2
2020	0	1	1
2021	1	1	2
2022	0	3	3
2023	0	1	1

Below are the most recent publications written about "Vaccines, Attenuated" by people in Profiles.

Rodriguez DM, Major CG, S?nchez-Gonz?lez L, Jones E, Delorey MJ, Alonso C, Rivera-Amill V, Paz-Bailey G, Adams LE. Dengue vaccine acceptability before and after the availability of COVID-19 vaccines in Puerto Rico. Vaccine. 2023 06 01; 41(24):3627-3635.

View in: PubMed
Saringkarisate K, Len KA, Melish ME, Prothero BK, Ching N. Vaccine-Strain Varicella Virus Transmitted to a Term Infant Following Maternal Postpartum Vaccination. J Pediatric Infect Dis Soc. 2022 Oct 25; 11(10):452-453.

View in: PubMed
Bamouh Z, Hamdi J, Elkarhat Z, Fellahi S, Omari Tadlaoui K, Watts DM, Fassi Fihri O, Elharrak M. Attenuation and genetic characteristics of a Moroccan strain of Camel pox virus. Vaccine. 2022 10 26; 40(45):6471-6480.

View in: PubMed
Watts DM, Westover JLB, Palermo PM, Bailey KW, Morrill JC, Bettinger GE, Monath TP, Smith DR, Peters CJ, Pittman PR, Orbegozo J, Gowen BB. Estimation of the Minimal Rift Valley Fever Virus Protective Neutralizing Antibody Titer in Human Volunteers Immunized with MP-12 Vaccine Based on Protection in a Mouse Model of Disease. Am J Trop Med Hyg. 2022 11 14; 107(5):1091-1098.

View in: PubMed
Rosenzweig JA, Hendrix EK, Chopra AK. Plague vaccines: new developments in an ongoing search. Appl Microbiol Biotechnol. 2021 Jun; 105(12):4931-4941.

View in: PubMed
Ricci G, Minsker K, Kapish A, Osborn J, Ha S, Davide J, Califano JP, Sehlin D, Rustandi RR, Dick LW, Vlasak J, Culp TD, Baudy A, Bell E, Mukherjee M. Flow virometry for process monitoring of live virus vaccines-lessons learned from ERVEBO. Sci Rep. 2021 04 01; 11(1):7432.

View in: PubMed
Perelygina L, Icenogle J, Sullivan KE. Rubella virus-associated chronic inflammation in primary immunodeficiency diseases. Curr Opin Allergy Clin Immunol. 2020 12; 20(6):574-581.

View in: PubMed
Stauft CB, Song Y, Gorbatsevych O, Pantoja P, Rodriguez IV, Futcher B, Sariol CA, Wimmer E. Extensive genomic recoding by codon-pair deoptimization selective for mammals is a flexible tool to generate attenuated vaccine candidates for dengue virus 2. Virology. 2019 11; 537:237-245.

View in: PubMed
Nyundo S, Adamson E, Rowland J, Palermo PM, Matiko M, Bettinger GE, Wambura P, Morrill JC, Watts DM. Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12?NSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania. Onderstepoort J Vet Res. 2019 Jan 31; 86(1):e1-e8.

View in: PubMed
Diaz C, Lin L, Martinez LJ, Eckels KH, Campos M, Jarman RG, De La Barrera R, Lepine E, Toussaint JF, Febo I, Innis BL, Thomas SJ, Schmidt AC. Phase I Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico. Am J Trop Med Hyg. 2018 05; 98(5):1435-1443.

View in: PubMed

People

Explore

Similar Concepts

Top Journals